Athersys Awarded $3.6 Million in Grant Funding For Stem Cell Product Development
Funding supports advancement for treatment of neurological and cardiovascular conditions & advanced manufacturing platform
03-Feb-2012 -
Athersys, Inc. announced grant funding aggregating $3.6 million to further advance its MultiStem® product programs and cell therapy platform. Specifically, Athersys was awarded a SBIR Fast-Track grant of up to $1.9 million from the National Institute of Neurological Disorders and Stroke (NINDS) ...
cardiovascular diseases
cell therapies
traumatic brain injuries